Berberis Complete

Medicinal Ingredients (Per Capsule) Barberry (Berberis vulgaris) Root and Stem Extract (4:1) – 200 mg (800 mg dried equivalent) Oregon Grape (Mahonia aquifolium) Root Extract (4:1) – 200 mg (800 mg dried equivalent) Goldenseal (Hydrastis canadensis) Root Standardized Extract (10:1, 5% alkaloids) – 50 mg (500 mg dried equivalent) Barberry (Berberis vulgaris) Root Bark – 25 mg Oregon Grape (Mahonia aquifolium) Root – 25 mg Non-Medicinal Ingredients: Hypromellose (capsule), cellulose, silica

Clinical Rationale & Mechanism of Action 1. Berberine as a Bioactive Alkaloid Berberine is a potent plant alkaloid with broad-spectrum antimicrobial, anti-inflammatory, and gastrointestinal regulatory effects. Found in high concentrations in barberry, Oregon grape, and goldenseal, it exerts its effects by influencing mucosal integrity, ion transport, motility, and microbial adhesion. 2. Gastrointestinal Barrier Protection Berberine supports epithelial tight junction formation and reduces intestinal permeability, thereby enhancing gut barrier function and mitigating "leaky gut" symptoms.⁵ 3. Anti-Diarrheal Mechanism Modulates ion and water transport across epithelial cells by upregulating Na⁺/H⁺ exchangers and aquaporins, reducing excess water in the bowel and helping to manage diarrhea.³˒⁴ 4. Regulation of Intestinal Motility In states of reduced gut contractility, berberine stimulates the jejunum via muscarinic receptor activation, improving sluggish digestion and offering mild laxative benefits.⁶ 5. Antimicrobial Properties Inhibits bacterial adhesion to gastric mucosa, a key step in the prevention of pathogen colonization and biofilm formation.³ Therapeutic Applications Traditionally Used In Herbal Medicine For: Alleviating dyspepsia and indigestion Acting as a bitter to stimulate digestive secretions Providing mild laxative action in cases of sluggish bowel function Clinically Supported For: Managing dysbiosis and small intestinal bacterial overgrowth (SIBO) Reducing post-infectious or inflammatory gut permeability Complementing protocols for irritable bowel syndrome (IBS) Supporting microbial balance in cases of Candida or parasitic infections

Javadzadeh, SM, Ebrahimi, A. Sci. Agri. 2013; 1(2): 61-66. Siow, YL, Sarna, L, O, K. Food Research International. 2011; 44: 2409-2417. Chen, C, Yu, Z, Li, Y, Fichna, J, Storr, M. The American Journal of Chinese Medicine. 2014; 42(5): 1053-1070. Zhang, Y, Wang, X, Sha, S, Liang, S, Zhao, L, Liu, L, Chai, N, Wang, H, Wu, K. Fitoterapia. 2012; 83: 1014-1022. Gu, L, Li, N, Gong, J, Li, Q, Zhu, W, Li, J. The Journal of Infectious Diseases. 2011; 203: 1602-1612. Chen, DP, Xiong, YJ, Lv, BC, Liu, FF, Wang, L, Tang, ZY, Lin, Y. Journal of Pharmacy and Pharmacology. 2013; 65(5): 734-744.